Form 8-K - Current report:
SEC Accession No. 0001171843-26-002146
Filing Date
2026-04-01
Accepted
2026-04-01 08:29:01
Documents
13
Period of Report
2026-04-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_040126.htm   iXBRL 8-K 15766
2 PRESS RELEASE exh_991.htm EX-99.1 10929
  Complete submission text file 0001171843-26-002146.txt   228489

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gnw-20250101.xsd EX-101.SCH 3402
4 XBRL DEFINITION FILE gnw-20250101_def.xml EX-101.DEF 26066
5 XBRL LABEL FILE gnw-20250101_lab.xml EX-101.LAB 35956
6 XBRL PRESENTATION FILE gnw-20250101_pre.xml EX-101.PRE 24702
17 EXTRACTED XBRL INSTANCE DOCUMENT f8k_040126_htm.xml XML 2801
Mailing Address 2400 SKYMARK AVENUE, UNIT 6 MISSISSAUGA A6 L4W 5K5
Business Address 2400 SKYMARK AVENUE, UNIT 6 MISSISSAUGA A6 L4W 5K5 647-476-1350
Profound Medical Corp. (Filer) CIK: 0001628808 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39032 | Film No.: 26824812
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)